Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Shows Positive Effects in Year Two of RMS Drug Trial
Drug Discovery and Development
Friday, September 12, 2014 - 8:47am
tags:
Biogen Idec, Plegridy, RMS
Safety warnings will hold back new obesity treatment Contrave
Pharmaphorum
Friday, September 12, 2014 - 8:41am
tags:
Orexigen, Takeda, obesity, Contrave
Novartis commits $20M to build a new CAR-T development center at Penn
Fierce Biotech
Friday, September 12, 2014 - 8:39am
tags:
Novartis, R&D, CAR-T
Japanese Research Scandal Involving Novartis Blood Pressure Drug Widens
Forbes
Friday, September 12, 2014 - 8:33am
tags:
Novartis, Japan, Diovan
Medtronic Looking To Boost Cardiovascular Therapeutic Revenue
Bidness Etc.
Friday, September 12, 2014 - 8:29am
tags:
Medtronic, devices, NC Euphora
Merck KGaA ends lung cancer vaccine trials
Yahoo/Reuters
Friday, September 12, 2014 - 8:27am
tags:
Merck KGaA, lung cancer, vaccines, Stimuvax
India's Lupin in deal to market U.S. firm Salix's drugs in Canada
Yahoo/Reuters
Friday, September 12, 2014 - 8:17am
tags:
Lupin, Salix, India, Canada
Pfizer confirms that it has dropped the idea of acquiring AstraZeneca; is now eyeing other viable acquisitions such as Actavis
Bidness Etc.
Friday, September 12, 2014 - 8:06am
tags:
Pfizer, AstraZeneca, M&A, Actavis
Google's stealthy Calico inks an R&D deal for new compounds aimed at neurodegeneration
Fierce Biotech
Thursday, September 11, 2014 - 5:24pm
tags:
Google, Calico, R&D, neurodegenerative disease
Ebola-Stricken Doc Receives Experimental Drug, But Which One?
TheStreet.com
Thursday, September 11, 2014 - 5:22pm
tags:
ebola virus, Tekmira Pharmaceuticals, TKM-EBOLA
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised
TheStreet.com
Thursday, September 11, 2014 - 5:21pm
tags:
Orexigen, Contrave, FDA, obesity
Novo’s Weight-Loss Shot Wins Backing of U.S. Advisers
Bloomberg
Thursday, September 11, 2014 - 4:44pm
tags:
Novo Nordisk, FDA, obesity, vaccines, Saxenda, liraglutide
J&J Plans for the Future by Trimming Pension Benefits for New Hires
WSJ Pharmalot
Thursday, September 11, 2014 - 4:40pm
tags:
JNJ, pensions
FDA Advisory Panel Offers Cautious Support For Polypill
Forbes
Thursday, September 11, 2014 - 11:44am
tags:
FDA, polypill, advisory panels
Allergan vs. Valeant: Where’s Perry Mason When You Need Him?
Barron's
Thursday, September 11, 2014 - 11:36am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Allergan investors owning 35 pct to demand special meeting-sources
Yahoo/Reuters
Thursday, September 11, 2014 - 11:34am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Fierce Biotech
Thursday, September 11, 2014 - 10:46am
tags:
Virobay, IPOs, autoimmune disease, painkillers
Biogen Idec Inc Suddenly Struggling To Keep Up With The Biotech Joneses
Yahoo/Benzinga
Thursday, September 11, 2014 - 10:25am
tags:
Biogen Idec
Takeda on track for dengue vax nods in 2017-18
Fierce Vaccines
Thursday, September 11, 2014 - 8:57am
tags:
Takeda, vaccines, dengue, Sanofi
Sanofi aims to grow Genzyme unit with new drugs and acquisitions
Yahoo/Reuters
Thursday, September 11, 2014 - 8:48am
tags:
Sanofi, Genzyme, Aubagio, Lemtrada

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.